AAOI Soars 15%! Will CFO's Speech Reveal Bombshell Tomorrow? Q3 Expected to Earn 24 Million

Published on 2026-08-17Last updated on 2026-08-17

Abstract

Applied Optoelectronics Inc. (NASDAQ:AAOI) shares rose 15.53% on Friday, closing at $150.28 per share, as investors began adjusting their portfolios in anticipation of a significant business update.

Applied Optoelectronics, Inc. (NASDAQ:AAOI) shares rose 15.53% on Friday, closing at $150.28 per share, as investors adjusted their portfolios in anticipation of significant business updates.

According to the company, Chief Financial and Strategy Officer Stefan Murray will be presenting at the Rosenblatt 6th Annual Technology Summit on Tuesday, August 18.

Investors are likely to focus on the company's updated outlook and targets, as well as its performance during the first few weeks of the third quarter.

Optimistic Outlook

Earlier this month, Applied Optoelectronics (NASDAQ:AAOI) issued its third-quarter revenue guidance, projecting revenue between $255 million and $290 million. This represents an increase of 115% to 144% compared to the $118.6 million reported in the same period last year, driven primarily by confidence in strong demand for its 800G and 1.6T transceivers.

The company also anticipates turning a net profit of $10.1 million to $24 million, compared to a net loss of $5.4 million in the prior-year period.

Multi-Million Dollar Orders in Q2

The stock's rise may also be fueled by new deals secured in March and the second quarter.

On March 9 alone, Applied Optoelectronics (NASDAQ:AAOI) received its first volume order for 1.6T data center transceivers from a longstanding customer, aiming to increase network bandwidth for its AI workloads.

A few weeks later, the company secured an order from a hyperscale data center customer for its 800G single-mode data center transceivers to support network capacity for its AI-driven workloads.

On April 2, Applied Optoelectronics (NASDAQ:AAOI) stated that the same customer placed an additional $71 million order for the same data center transceivers, bringing the latter's total order value to $124 million.

Expansion Underway

To meet robust market demand, the company is expanding its facilities in Pearland and Sugar Land, Texas, to increase its production capacity.

The Pearland site alone will add two adjacent buildings, equivalent to 388,000 square feet of production capacity, with construction formally commencing earlier this year.

The company also received a $20.8 million innovation fund grant from the state of Texas to support its production expansion in Sugar Land.

The facility in Sugar Land is currently under construction and, upon completion, will expand its footprint by 210,000 square feet. This site is set to become one of the company's largest U.S. facilities dedicated to AI data center transceivers and is expected to create over 500 new jobs.

Hedge Funds Buying

Institutional investors have shown strong confidence in the company, evidenced by an increased number of participating hedge funds and a 215% surge in their total investments.

Data from Insider Monkey shows that 55 hedge funds held stakes in Applied Optoelectronics (NASDAQ:AAOI) in the first quarter of this year—coinciding with a surge in orders for its optics products. This number is higher than the 36 funds in the previous quarter.

Notably, their collective holdings more than tripled from $277 million in Q4 2024 to $871.3 million, indicating a significant rise in bullish sentiment among large investors towards the stock.

Related Reads

Not Chasing AI or Buying Back Shares, Can 'Stingy' Jingdong Still Succeed?

On August 13th, JD.com (JD.US) released its Q2 2026 earnings, delivering a mixed and generally "flat" performance that met low expectations but offered few positives. Overall revenue declined by approximately 3% year-over-year (YoY) to ~¥346.4 billion, aligning with weakened domestic consumption trends. While group operating profit saw a YoY improvement, this was primarily due to reduced losses in the food delivery segment compared to the high-cost "delivery war" period of the previous year. Key details reveal deeper concerns: revenue from JD's core domestic retail segment fell 4.7% YoY. While electronics sales declined less than feared (~12% YoY), growth in daily necessities and advertising services plummeted by about 10 percentage points each, raising doubts about the segment's mid-term growth momentum post-subsidy adjustments. Logistics revenue growth also slowed to 5.9% as the delivery boom faded. Profitability presented a nuanced picture. The retail segment's operating margin edged up slightly YoY but failed to deliver the significant beats seen in past quarters, suggesting efficiency gains may be nearing limits. Losses from the New Businesses segment (including food delivery and overseas ventures) remained elevated at ~¥9.9 billion, as increased overseas investment partially offset reductions in delivery subsidies. Notably, JD's shareholder returns weakened significantly, with share buybacks in H1 2026 annualizing to only about 5% of market cap. The company opted to park cash in short-term investments rather than boost returns, drawing criticism. Looking ahead, JD's performance hinges on a potential recovery in China's e-commerce sentiment in H2 2026 and the scale of ongoing losses in new ventures. While not burdened by massive AI capex like some peers, and offering relative defensive stability, the lack of positive earnings surprises and diminished shareholder returns provide little compelling reason for investors to favor the stock in the near term.

marsbit7m ago

Not Chasing AI or Buying Back Shares, Can 'Stingy' Jingdong Still Succeed?

marsbit7m ago

CEO or 'Cult Leader'? Anthropic Faces Backlash Over Its 'Belief'

Anthropic, an AI company nearing trillion-dollar valuation, faces a critical internal challenge: declining morale and a growing rift over its foundational beliefs and leadership. While financial and technical performance remains strong, with Q2 2026 revenue surging over 14x year-over-year and top talent like Google's Justin Gilmer joining, the company's unique culture is under strain. Early employees, who embraced a strong mission-focused culture around AI safety, now coexist with newer hires less aligned with this vision. Anonymous sources report low morale, private channels for airing grievances, and employees torn between staying for valuable equity or leaving due to pressure. CEO Dario Amodei's intense focus on maintaining culture—through rituals like "Dario Vision Quest" meetings and probing "cultural interviews"—faces scrutiny as the company scales. A leaked statement where Amodei suggested Anthropic could one day become "the world's only private company" has fueled external criticism, drawing comparisons to dystopian sci-fi monopolies. The company exhibits contradictions: advocating for AI safety while aggressively pursuing model development and market dominance. It has modified its "Responsible Scaling Policy," faced backlash for attempted AI "sabotage" mechanisms against foreign research, and clashed with the U.S. government over defense contracts. Recent text watermarking for Claude, cited as compliance with EU regulations, has also drawn user criticism. Despite these tensions, Anthropic continues to attract investment, top engineers, and enterprise clients. However, the core "faith" that once unified and distinguished it is now becoming a significant governance and cultural challenge.

marsbit42m ago

CEO or 'Cult Leader'? Anthropic Faces Backlash Over Its 'Belief'

marsbit42m ago

Anthropic CEO Denies Rumors, Aims to Transform AI for His Deceased Father and Eradicate Cancer Within 10 Years

Anthropic CEO Dario Amodei has published a rare, lengthy public statement to counter significant criticism from Silicon Valley, as the AI company approaches a potential record-breaking IPO with a reported $2 trillion valuation. The core criticism, amplified by investor Gavin Baker, centers on perceptions that Amodei believes Anthropic should be the world's sole private AI company due to the technology's risks, costs, and power—a view allegedly echoed by NVIDIA's Jensen Huang. Amodei firmly rejects this, arguing it presents a false dichotomy. He defends Anthropic's advocacy for regulation, like California's SB-1047, which he claims imposes costs on frontier AI firms while benefiting smaller competitors, and calls for establishing rules that manage AI risks, constrain corporate power, and preserve open-model development. Shifting to ambition, Amodei outlines a radical vision for AI in biomedicine. He states that within 5-10 years, AI could cure most human diseases, a mission deeply personal due to his father's death from hepatitis C just years before a cure became available. Amodei asserts that public trust in AI will be earned not by promises or benchmarks, but by tangible results—AI actually saving lives. He confirms Anthropic is significantly increasing its biology and medical AI investments, with preliminary results expected within months. This narrative reframing comes ahead of Anthropic's anticipated IPO, positioning the company not just as an OpenAI competitor, but as one aiming to solve humanity's fundamental challenges.

marsbit43m ago

Anthropic CEO Denies Rumors, Aims to Transform AI for His Deceased Father and Eradicate Cancer Within 10 Years

marsbit43m ago

Trading

Spot
活动图片